Circulating tumor cell counts are powerful prognostic factors for cancer patients. Recent research has found…
To speed up drug development and commercialization, most biotechs partner with contract development and manufacturing…
Partnering events are unique opportunities for biotechs to present their projects to potential investors and…
Advancing a drug to market readiness is a major milestone. After successfully completing clinical studies,…
The success of a new drug depends on much more than its efficacy and safety…
Tech transfer appears on the agenda of almost every biotech company. After identifying a suitable…
Standardized, carefully managed samples are indispensable for the success of any clinical study. Still, sample…
In 2020, fundraising seems like an even bigger challenge than before. The biotech industry, however,…
Immune cell monitoring is imperative for almost any clinical study. The problem: Current procedures require…
Bioburden detection is one of the quality control measures required to ensure drug safety –…
With the recent outbreaks of plague in Madagascar and Ebola in West Africa, two terrifying…
May 5, 2017, saw the first FDA approval for an amyotrophic lateral sclerosis (ALS) drug…
